Berlin-based Vara, a startup developing an AI system to screen breast cancer, announced on Tuesday that it has secured €4.5M in a Series A extension round, taking the total Series A funding raised to €11M.
The round was led by Swiss venture capital firm VI Partners, with participation from EQT Foundation, Med360, AI Venture Studio, Merantix, and Think Health.
The German company says it will use the capital to provide 1 billion women worldwide access to better screening, particularly in underfunded areas, to detect breast cancer earlier.
Founded by Jonas Muff and Stefan Bunk in 2016, Vara is an AI-powered breast cancer screening platform.
According to the company, integrating artificial intelligence into breast cancer screening could significantly reduce workloads, complementing the work of radiologists and increasing sensitivity and specificity.
The German company now powers five screening centers across Mexico in partnership with Mamotest, a breast cancer screening provider, and partnered with MITERA, the largest Private Hospital in Greece.
Read more on Tech Gist Africa:
Berlin-based Handly raises €1.5M
